Architecture AWS Compliance Pharmaceuticals 
AWS Machine Learning - AI
FEBRUARY 6, 2024
In 2021, the pharmaceutical industry generated $550 billion in US revenue. Pharmaceutical companies sell a variety of different, often novel, drugs on the market, where sometimes unintended but serious adverse events can occur. We implemented the solution using the AWS Cloud Development Kit (AWS CDK).
CIO
DECEMBER 18, 2023
Other fears cover compliance with emerging AI regulations and the risk of models becoming contaminated or biased through adversarial attacks. For example, one pharmaceutical company using ChatGPT4 or similar for corporate espionage could essentially spy on its competitor’s research queries.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Lacework
JANUARY 17, 2024
He excels in security, risk, compliance, and privacy, having established cybersecurity practices in four companies. LinkedIn Chris Betz Amazon Web Services Chris Betz, AWS CISO, is revolutionizing cloud security with a focus on AI, customer trust, and the Zero Trust model.
Altexsoft
APRIL 23, 2021
Our dedicated article will provide you with more details on the IoT architecture layers and components. Smart pills , also known as smart drugs or digital pills, are small electronic devices that come in the form of pharmaceutical capsules containing ingestible sensors. Take care of regulatory compliance.
CIO
AUGUST 18, 2022
The giant pharmaceutical chain had put its lakehouse in place to address just such challenges in its quest, to, as Guadagno puts it, “To get the right product in the right place for the right patient.”. Moonfare selected Dremio in a proof-of-concept runoff with AWS Athena, an interactive query service that enables SQL queries on S3 data.
Existek
OCTOBER 18, 2023
With advancements driven by research breakthroughs, increased computing power, larger datasets, and innovative model architectures, it introduced sophisticated generative AI models. Pharmaceutical companies gain the potential to transform their domain and lead to the discovery of more effective treatments for various diseases.
CIO
DECEMBER 14, 2023
Caveat emptor in the cloud Bob McGowan, CIO of Regeneron Pharmaceuticals, acknowledges the risk of cloud concentration is valid but he is more concerned about the readiness of SaaS partners. “If It is no longer a decision between AWS and Azure. Once you adopt their cloud platforms, it can be difficult and expensive to migrate out.
Expert insights. Personalized for you.
94 
Let's personalize your content